Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Scott Harris

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Gastroenterology|January 10, 2019
Innovative Trial Designs in GI Drug Development: Why Trials Succeed and Fail-A Brief Report From 2018 Digestive Disease WeekM Scott Harris, Colin W Howden
Gastroenterology|October 19, 2019
FDA Town Hall-New Drug Approvals in Gastrointestinal Disease (2018-2019)M Scott Harris, Colin W Howden,
Gastroenterology|July 16, 2019
ReplyM Scott Harris, Colin W Howden
Gastroenterology|August 25, 2019
Competition for Clinical Trials in Inflammatory Bowel DiseasesM Scott Harris, Jolanta Wichary, Matt Zadnik, et al.
Gastroenterology|April 3, 2020
ReplyM Scott Harris, Jolanta Wichary, Matt Zadnik, et al.
Inflammatory Bowel Diseases|April 4, 2014
AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled studyWalter Reinisch, Simon Travis, Stephen Hanauer, et al.
Scientific Reports|April 24, 2022
Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitisJohn J Nestor, David Parkes, Michael Feigh, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2011
Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studiesW J Sandborn, S Hanauer, G R Lichtenstein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2014
Placebo response rate in clinical trials of fistulizing Crohn's disease: systematic review and meta-analysisAlexander C Ford, Pavit Luthra, Stephen B Hanauer, et al.
Neurogastroenterology and Motility|February 5, 2020
The effects of ulimorelin, a ghrelin agonist, on liquid gastric emptying and colonic transit in humansJoyce James, Stuart Mair, Walter Doll, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Gastroenterology|January 10, 2019
Innovative Trial Designs in GI Drug Development: Why Trials Succeed and Fail-A Brief Report From 2018 Digestive Disease WeekM Scott Harris, Colin W Howden
Gastroenterology|October 19, 2019
FDA Town Hall-New Drug Approvals in Gastrointestinal Disease (2018-2019)M Scott Harris, Colin W Howden,
Gastroenterology|July 16, 2019
ReplyM Scott Harris, Colin W Howden
Gastroenterology|August 25, 2019
Competition for Clinical Trials in Inflammatory Bowel DiseasesM Scott Harris, Jolanta Wichary, Matt Zadnik, et al.
Gastroenterology|April 3, 2020
ReplyM Scott Harris, Jolanta Wichary, Matt Zadnik, et al.
Inflammatory Bowel Diseases|April 4, 2014
AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled studyWalter Reinisch, Simon Travis, Stephen Hanauer, et al.
Scientific Reports|April 24, 2022
Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitisJohn J Nestor, David Parkes, Michael Feigh, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2011
Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studiesW J Sandborn, S Hanauer, G R Lichtenstein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2014
Placebo response rate in clinical trials of fistulizing Crohn's disease: systematic review and meta-analysisAlexander C Ford, Pavit Luthra, Stephen B Hanauer, et al.
Neurogastroenterology and Motility|February 5, 2020
The effects of ulimorelin, a ghrelin agonist, on liquid gastric emptying and colonic transit in humansJoyce James, Stuart Mair, Walter Doll, et al.
Pageof 3